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Meitinger et al., http ://www .jcb .org /cgi /content /full /jcb .201604081 /DC1 Figure S1 . Results from the CRI SPR/Cas9 screen. (A) Table shows the gRNAs identified in each of the 15 type 1 colonies obtained in both screens. For this analysis, gRNAs were amplified from each colony, cloned, and identified by Sanger sequencing. All type 1 colonies contained a gRNA targeting TP53BP1 (blue), USP28 (green), or TRIM37 (red). (B) For the first screen, a second approach was also taken in which all 32 colonies (6 type 1 and 26 type 2) were pooled. The gRNAs were then amplified and subjected to Illumina sequencing. The top hits from this analysis (according to the gRNA counts) included the genes encoding the expected type 2 hits p53 (TP53; orange) and p21 (CDKN1A; purple) as well as the type 1 hits TP53BP1, USP28, and TRIM37. Figure S2 . Generation and characterization of single TP53BP1, USP28, and TRIM37 knockout mutants. (A) Locations of the gRNAs (asterisks) used to generate the single deletion mutants in the TP53BP1, USP28, and TRIM37 genes, along with the locations in the corresponding proteins. (B) Immunofluorescence images acquired using spinning disk confocal optics of control (top row) or knockout (bottom row) RPE1 cells stained for DNA and 53BP1 (left) or DNA and USP28 (right). Bar, 50 µm. (C) Graph shows the centrosome number distribution in control or knockout RPE1 cell lines after 5-d treatment with DMSO or centrinone. Centrosomes were identified as foci costaining for γ-tubulin and Cep192. Data from three experiments were analyzed. Error bars are SD. (D) Control or knockout RPE1 cell lines were treated with centrinone or DMSO (vehicle control) for 5 d and fixed and stained for DNA and with antibodies to Cep192 and p53. The graph shows mean nuclear p53 fluorescence for two independent experiments (experiments 1 and 3; data for experiment 2 are plotted in Fig. 2 E) . Graph shows 5-95% box-and-whiskers plots. (E) Immunoblot shows p53 levels after 12, 24, and 48 h of centrinone treatment. Schematic summarizes the result relative to the kinetics of centrosome depletion (Wong et al., 2015) . (F) Schematic outlines the experiment performed to test whether reducing mitotic duration using the Mps1 inhibitor NMS-P715 can suppress centrinone-induced p53 elevation. Cells were pretreated for 24 h with centrinone, at which point the majority of cells have one centrosome and do not yet have elevated p53 (see schematic and blot in E). The cells were then incubated with centrinone plus the specific Mps1 inhibitor NMS-P715 for an additional 24 h to determine whether it was possible to block the p53 elevation that normally occurs as the first wave of cells go from having one to zero centrosomes. In addition to monitoring the experiment by Western blotting, cells (which expressed RFP::H2B) were monitored by live cell filming. Shown are an immunoblot for p53 levels (left), a graph plotting mitotic duration, shown as 5-95% box-and-whiskers plots (middle), and a graph plotting the percentage of cells that failed chromosome segregation and cytokinesis (right). Video 1. Mitosis in control DMSO-treated RPE1 and DMSO-and centrinone-treated p53 knockdown (sh-TP53), TP53BP1Δ, USP28Δ, and TRIM37Δ cells. Cells were treated for 5 d with DMSO or centrinone before collection of a 5 × 2-µm confocal z-series every 4 min for 8 h. Four representative examples are shown for each condition. Images are maximum-intensity projections. Images were acquired on a CV7000 spinning disk confocal system (Yokogawa Electric Corporation) equipped with a 40× (0.95 NA) U-PlanApo objective and 2,560 × 2,160-pixel sCMOS camera (Andor Technology). Playback rate is 1,168× real time (5 frames/s). 
